An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Investigational Drug Gaining Traction Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.
Several experts stated the demand for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, marketing, and consumer laws, potentially leading to fines, prosecution or prison.
Platform Reaction and Content Elimination
Based on the social media company, the service has removed problematic material and banned related hashtags and search suggestions. The organization stated it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Operations
Research also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with numerous of members, populated with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at home.
Within minutes of entering one group, a vendor shared contact information, where most purchases occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, medical conditions or past usage.
Product Information and Pricing
Within these communities, posts display black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they cannot confirm. Even if the research behind this drug is sound, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered patients injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to potentially serious health risks”.
